Status:
COMPLETED
Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms
Lead Sponsor:
Upsher-Smith Laboratories
Conditions:
Postmenopausal Symptoms
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.
Eligibility Criteria
Inclusion
- Postmenopausal women
- Have moderate to severe hot flashes
- Normal Pap Smear
Exclusion
- Abnormal mammogram
- Abnormal clinical breast exam
- BMI \>35
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
495 Patients enrolled
Trial Details
Trial ID
NCT00727129
Start Date
July 1 2004
End Date
August 1 2005
Last Update
September 26 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.